Connection
Katja Aviszus to Humans
This is a "connection" page, showing publications Katja Aviszus has written about Humans.
|
|
Connection Strength |
|
 |
|
 |
|
0.035 |
|
|
|
-
El Kharbili M, Sasse SK, Sanford L, Jacobson S, Aviszus K, Gupta A, Guo C, Majka SM, Dowell RD, Gerber AN, Bowler RP, Gally F. Noncoding SNPs decrease expression of FABP5 during COPD exacerbations. J Clin Invest. 2023 Dec 19; 134(3).
Score: 0.006
-
Liu H, Wei P, Aviszus K, Zhang Q, Linderberger J, Yang J, Liu J, Chen Z, Waheed H, Reynoso L, Downey GP, Frankel SK, Kappler JW, Marrack P, Zhang G. The Receptor Binding Domain of SARS-CoV-2 Lambda Variant Has a Better Chance Than the Delta Variant in Evading BNT162b2 COVID-19 mRNA Vaccine-Induced Humoral Immunity. Int J Mol Sci. 2022 Sep 26; 23(19).
Score: 0.005
-
El Kharbili M, Aviszus K, Sasse SK, Zhao X, Serban KA, Majka SM, Gerber AN, Gally F. Macrophage programming is regulated by a cooperative interaction between fatty acid binding protein 5 and peroxisome proliferator-activated receptor ?. FASEB J. 2022 05; 36(5):e22300.
Score: 0.005
-
Liu H, Zhang Q, Wei P, Chen Z, Aviszus K, Yang J, Downing W, Jiang C, Liang B, Reynoso L, Downey GP, Frankel SK, Kappler J, Marrack P, Zhang G. The basis of a more contagious 501Y.V1 variant of SARS-CoV-2. Cell Res. 2021 06; 31(6):720-722.
Score: 0.005
-
Liu H, Wei P, Zhang Q, Chen Z, Aviszus K, Downing W, Peterson S, Reynoso L, Downey GP, Frankel SK, Kappler J, Marrack P, Zhang G. 501Y.V2 and 501Y.V3 variants of SARS-CoV-2 lose binding to bamlanivimab in vitro. MAbs. 2021 Jan-Dec; 13(1):1919285.
Score: 0.005
-
Phalke S, Aviszus K, Rubtsova K, Rubtsov A, Barkes B, Powers L, Warner B, Crooks JL, Kappler JW, Fern?ndez-P?rez ER, Maier LA, Hamzeh N, Marrack P. Age-associated B Cells Appear in Patients with Granulomatous Lung Diseases. Am J Respir Crit Care Med. 2020 10 01; 202(7):1013-1023.
Score: 0.005
-
Detanico T, St Clair JB, Aviszus K, Kirchenbaum G, Guo W, Wysocki LJ. Somatic mutagenesis in autoimmunity. Autoimmunity. 2013 Mar; 46(2):102-14.
Score: 0.003
-
Shapiro GS, Aviszus K, Murphy J, Wysocki LJ. Evolution of Ig DNA sequence to target specific base positions within codons for somatic hypermutation. J Immunol. 2002 Mar 01; 168(5):2302-6.
Score: 0.001
-
Shapiro GS, Aviszus K, Ikle D, Wysocki LJ. Predicting regional mutability in antibody V genes based solely on di- and trinucleotide sequence composition. J Immunol. 1999 Jul 01; 163(1):259-68.
Score: 0.001
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|